Pesquisa | BVS Violência e Saúde

1.

Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations.

Balestrino, R; Martone, T; Toffoli, M; Montanaro, E; Fabbri, M; Artusi, C A; Romagnolo, A; Zibetti, M; Rizzone, M; Goldwurm, S; Lopiano, L; Schapira, A H V.

Neurol Sci ; 45(4): 1489-1497, 2024 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-37926749

2.

Parkinson disease.

Balestrino, R; Schapira, A H V.

Eur J Neurol ; 27(1): 27-42, 2020 01.

Artigo em Inglês | MEDLINE | ID: mdl-31631455

3.

Neurological effects of glucocerebrosidase gene mutations.

Mullin, S; Hughes, D; Mehta, A; Schapira, A H V.

Eur J Neurol ; 26(3): 388-e29, 2019 03.

Artigo em Inglês | MEDLINE | ID: mdl-30315684

4.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso, J A; Stamelou, M; Goetz, C G; Poewe, W; Lang, A E; Weintraub, D; Burn, D; Halliday, G M; Bezard, E; Przedborski, S; Lehericy, S; Brooks, D J; Rothwell, J C; Hallett, M; DeLong, M R; Marras, C; Tanner, C M; Ross, G W; Langston, J W; Klein, C; Bonifati, V; Jankovic, J; Lozano, A M; Deuschl, G; Bergman, H; Tolosa, E; Rodriguez-Violante, M; Fahn, S; Postuma, R B; Berg, D; Marek, K; Standaert, D G; Surmeier, D J; Olanow, C W; Kordower, J H; Calabresi, P; Schapira, A H V; Stoessl, A J.

Mov Disord ; 32(9): 1264-1310, 2017 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-28887905

5.

Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.

Leone, M A; Keindl, M; Schapira, A H; Deuschl, G; Federico, A.

Eur J Neurol ; 22(12): 1505-10, 2015 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-26268048

6.

The timing of deep brain stimulation for Parkinson disease in the UK from 1997 to 2012.

deSouza, R M; Akram, H; Low, H L; Green, A L; Ashkan, K; Schapira, A H V.

Eur J Neurol ; 22(10): 1415-7, 2015 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-26371441

7.

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.

Marin, C; Bonastre, M; Mengod, G; Cortés, R; Giralt, A; Obeso, J A; Schapira, A H.

Neurobiol Dis ; 64: 36-47, 2014 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-24370700

8.

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.

Hauser, R A; Schapira, A H V; Barone, P; Mizuno, Y; Rascol, O; Busse, M; Debieuvre, C; Fraessdorf, M; Poewe, W.

Eur J Neurol ; 21(5): 736-43, 2014 May.

Artigo em Inglês | MEDLINE | ID: mdl-24834511

9.

Progress in neurology 2017-2018.

Schapira, A H V.

Eur J Neurol ; 25(12): 1389-1397, 2018 12.

Artigo em Inglês | MEDLINE | ID: mdl-30347488

10.

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.

Schapira, A H V; Barone, P; Hauser, R A; Mizuno, Y; Rascol, O; Busse, M; Debieuvre, C; Fraessdorf, M; Poewe, W.

Eur J Neurol ; 20(1): 50-6, 2013 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-22537207

11.

Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease.

Schapira, A H V; Stocchi, F; Borgohain, R; Onofrj, M; Bhatt, M; Lorenzana, P; Lucini, V; Giuliani, R; Anand, R.

Eur J Neurol ; 20(2): 271-80, 2013 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-22967035

12.

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.

Schapira, A H V; Barone, P; Hauser, R A; Mizuno, Y; Rascol, O; Busse, M; Debieuvre, C; Fraessdorf, M; Poewe, W.

Eur J Neurol ; 20(1): 180-7, 2013 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-22845710

13.

Advances and insights into neurological practice 2016-17.

Schapira, A H V.

Eur J Neurol ; 24(12): 1425-1434, 2017 12.

Artigo em Inglês | MEDLINE | ID: mdl-29034555

14.

Challenges to the development of disease-modifying therapies in Parkinson's disease.

Schapira, A H V.

Eur J Neurol ; 18 Suppl 1: 16-21, 2011 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-21255199

15.

Advances in neurological research and practice.

Schapira, A H V.

Eur J Neurol ; 23(12): 1685-1693, 2016 12.

Artigo em Inglês | MEDLINE | ID: mdl-27882727

16.

Sirkka-Liisa Leinonen.

Schapira, A H V; Albanese, A; Brainin, M; Davie, C; Juvela, S; Leone, M; Meschia, J; Saloheimo, P; Tan, E-K; Wszolek, Z.

Eur J Neurol ; 23(4): 673-4, 2016 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-25808730

17.

Mitochondrial matters of the brain: the role in Huntington's disease.

Turner, C; Schapira, A H V.

J Bioenerg Biomembr ; 42(3): 193-8, 2010 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-20480217

18.

Neurology in evolution 2014-2015.

Schapira, A H V.

Eur J Neurol ; 22(12): 1493-502, 2015 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-26538269

19.

The measurement and importance of non-motor symptoms in Parkinson disease.

Schapira, A H V.

Eur J Neurol ; 22(1): 2-3, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-25046771

20.

Genetic causes of PD: A pathway to disease modification.

Toffoli, M; Vieira, S R L; Schapira, A H V.

Neuropharmacology ; 170: 108022, 2020 06 15.

Artigo em Inglês | MEDLINE | ID: mdl-32119885

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations.

Parkinson disease.

Neurological effects of glucocerebrosidase gene mutations.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.

The timing of deep brain stimulation for Parkinson disease in the UK from 1997 to 2012.

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease.

Progress in neurology 2017-2018.

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.

Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease.

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.

Advances and insights into neurological practice 2016-17.

Challenges to the development of disease-modifying therapies in Parkinson's disease.

Advances in neurological research and practice.

Sirkka-Liisa Leinonen.

Mitochondrial matters of the brain: the role in Huntington's disease.

Neurology in evolution 2014-2015.

The measurement and importance of non-motor symptoms in Parkinson disease.

Genetic causes of PD: A pathway to disease modification.